Abstract | OBJECTIVE: METHODS: One hundred ninety patients with PCOS and simple EH without cytologic atypia were allocated randomly to 2 independent arms, that is, the LNG-IUS group (90 patients) and the non-LNG-IUS group (100 patients). Four hundred fourteen patients with PCOS without endometrial disease comprised the control group. Each patient was reevaluated by transvaginal ultrasonography (TVS) and endometrial biopsy after 6 months. For each patient, IVF outcome measures, such as number of recombinant follicle-stimulating hormone, endometrial thickness on human chorionic gonadotropin (HCG) day, hormone levels ( progesterone, luetinizing hormone, and serum estradiol) on HCG day, number of oocytes, fertilization rate, clinical pregnancy rate, and miscarriage rate were compared among the 3 groups. RESULTS: In general, the 3 groups did not differ with respect to the main clinical and biochemical data. After 6 months, patients in LNG-IUS group had an EH resolution rate of 87.77%. In the non-LNG-IUS group, the resolution rate was 15.00%, and 3% of these patients showed progression of EH. The clinical pregnancy rates in the non-LNG-IUS group were significantly lower (28.04%) than that in the LNG-IUS group (46.06%) and the control group (44.65%). The miscarriage rate was highest in the non-LNG-IUS group, but no significant difference in miscarriage rate existed among the 3 groups. CONCLUSION: The study illustrates that the LNG-IUS can be safely used for 6 months as a treatment for patients with PCOS and simple EH. Additionally, use of the LNG-IUS can increase the clinical pregnancy rates and implantation rates of patients with PCOS and simple EH who undergo gonadotropin-releasing hormone agonist IVF-ET protocols.
|
Authors | Jiang Bian, Hongfang Shao, Hua Liu, Hui Li, Lu Fang, Changying Xing, Lihong Wang, Minfang Tao |
Journal | Reproductive sciences (Thousand Oaks, Calif.)
(Reprod Sci)
Vol. 22
Issue 6
Pg. 758-66
(Jun 2015)
ISSN: 1933-7205 [Electronic] United States |
PMID | 25536958
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | © The Author(s) 2014. |
Chemical References |
- Fertility Agents, Female
- Levonorgestrel
|
Topics |
- Abortion, Spontaneous
(etiology)
- Adult
- Biopsy
- China
- Embryo Implantation
(drug effects)
- Embryo Transfer
(adverse effects)
- Endometrial Hyperplasia
(complications, diagnosis, drug therapy, physiopathology)
- Female
- Fertility Agents, Female
(administration & dosage, adverse effects)
- Fertilization in Vitro
(adverse effects)
- Humans
- Infertility, Female
(diagnosis, etiology, physiopathology, therapy)
- Intrauterine Devices, Medicated
(adverse effects)
- Levonorgestrel
(administration & dosage, adverse effects)
- Polycystic Ovary Syndrome
(complications, diagnosis, physiopathology)
- Pregnancy
- Pregnancy Rate
- Prospective Studies
- Time Factors
- Treatment Outcome
|